Traduction de «concerning the additives that are authorised » (Néerlandais → Français) :

For the moment, the Belgian legislation explicitly stipulates in a Royal Decree concerning the additives that are authorised in foodstuffs (RD of 1 March 1998) that the caffeine content in aromatised non-alcoholic beverages may not exceed 320 mg/litre.
A l’heure actuelle, la législation belge prévoit explicitement dans l’AR relatif aux additifs autorisés dans les denrées alimentaires (AR du 1er mars 1998) que la quantité maximale de caféine autorisée dans les boissons aromatisées sans alcool est de 320 mg/litre.

In 1995, the Council was consulted by the Food Inspection of the Ministry of Public Health in connection with a request from the firm that marketed “Red Bull” regarding the modification of the authorised content of an additive that was already on the list of authorised additives, viz. caffeine.
en 1995, le Conseil est consulté par l’Inspection des denrées alimentaires du Ministère de la Santé publique suite à une demande de la firme commercialisant le Red Bull pour envisager la modification de la teneur autorisée d’un additif déjà inscrit sur la liste d’additifs autorisés, en l’occurrence la caféine.

As for D-glucuronolactone, the group believes that this concerns a normal human metabolite deriving from glucose, which does not involve a structural risk with regard to mutagenicity or carcinogenicity. It also holds that both this component as well as its hydrolysis product, glucuronic acid, are endogenous metabolites in humans and other mammals, that they are naturally present in various food sources and that they are quickly metabolised into innocuous products and excreted.
Pour la D-glucuronolactone, le groupe considère qu’il s’agit d’un métabolite humain normal provenant du glucose qui ne présente pas de risque structural en termes de mutagénicité ou de carcinogénicité, que pour ce composant, comme pour son produit d’hydrolyse, l’acide glucuronique, il s’agit de métabolites endogènes chez l’homme et les autres mammifères, qu’ils se trouvent à l’état naturel dans diverses sources alimentaires et qu’ils sont rapidement métabolisés en produits sans danger et excrétés.

A few years later, the same SCF published an additional report that was triggered by the fact that the firm which produces “Red Bull” had made available further information and experimental data concerning the product.
Le même SCF a publié quelques années plus tard un rapport complémentaire suite à l’envoi par le principal fabriquant de ces boissons d’autres informations et données expérimentales sur le produit et suite à la prise en compte d’autres développements (SCF, 2003).

The reasons for these high numbers are: depression, loneliness, bad health, social isolation, loss of independence, loss of a partner or someone close… The elderly constitute a high-risk group as far as depression and suicide are concerned, but far too often, the depression is not noticed in time, one reason being that it is thought that those minor health problems in elderly people are caused by the “normal” process of growing old.
Les raisons de ces chiffres élevés sont la dépression, la solitude, un mauvais état de santé, l’isolement social, la perte de son indépendance, la perte du partenaire ou des proches… Les personnes âgées forment un groupe à risque pour la dépression et le suicide, mais trop souvent la dépression n’est pas détectée à temps entre autre car on croit que les « petits bobos » des personnes âgées sont dûs à un processus « normal » de vieillissement.

As for taurine, the experts emphasise that high taurine doses can result in neurological side effects. This concerns doses that are 36 times higher than the usual taurine intake by humans as regards the chronic consumption of this type of beverage and doses that are 6 times higher than the normal intake as regards their acute intake.
En ce qui concerne la taurine, les experts soulignent la possibilité d’induction d’effets secondaires de type neurologiques pour des doses élevées de taurine qui représenteraient 36 fois l’apport usuel estimé en taurine chez l’homme dans le cadre d’une prise chronique de ce type de boisson et 6 fois cet apport dans le cadre d’une prise aiguë de cette boisson.

It is also essential for rational and safe use of medicines that the information in advertising agrees with the elements approved of when the marketing authorisation (MA) for the medicine was granted. Healthcare professionals when making a therapeutic choice should not be influenced by elements that are not associated with the characteristics of the medicine.
It is also essential for rational and safe use of medicines that the information in advertising agrees with the elements approved of when the marketing authorisation (MA) for the medicine was granted. Healthcare professionals when making a therapeutic choice should not be influenced by elements that are not associated with the characteristics of the medicine.

Committee is primarily concerned with the ethical and medical aspects, and is the body that has to provide explicit authorisation to allow a clinical trial to start.
Committee is primarily concerned with the ethical and medical aspects, and is the body that has to provide explicit authorisation to allow a clinical trial to start.

It takes the view that the new results that are available are sufficient to respond to the previously expressed concern and concludes that the exposure to taurine at the above-mentioned levels does not lead to a safety issue.
Il estime que les nouveaux résultats mis à disposition sont suffisants pour répondre aux inquiétudes soulevées précédemment et conclut que l’exposition à la taurine aux niveaux mentionnés ci-dessus ne suscite pas d’inquiétudes en termes de sécurité.

There is one other fee that is notable for its intended purpose, since the “clinical trial” contribution (1,670,042 euros) will serve not just to cover the FAMHP’s costs but also and above all to finance the Ethics Committees. As far as the taxes are concerned, it should be
There is one other fee that is notable for its intended purpose, since the “clinical trial” contribution (1,670,042 euros) will serve not just to cover the FAMHP’s costs but also and above all to finance the Ethics Committees. As far as the taxes are concerned, it should be